Business Context and Reporting Period
Company: AgriForce Growing Systems, Ltd. (Note: Request metadata listed "AVAX ONE TECHNOLOGY LTD.", but the filing text identifies AgriForce Growing Systems, Ltd.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 15, 2024
Reporting Period: Specific event date of October 15, 2024.
Business Overview: The Company is an emerging growth company incorporated in British Columbia, Canada, with common shares and Series A warrants trading on The Nasdaq Capital Market under symbols AGRI and AGRIW, respectively.
Key Financial Metrics
This filing reports a specific capital raise event rather than periodic financial performance. The following metrics are derived from the transaction details:
- Capital Raised: $800,000 in total proceeds.
- Shares Issued: 16,000,000 common shares.
- Price Per Share: $0.05.
- Investors: Two institutional investors (each purchasing 8,000,000 shares for $400,000).
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these standard financial metrics. It only references the existence of outstanding Debentures defined in a prior agreement.
Material Changes
The primary material change is the entry into a Material Definitive Agreement (Item 1.01) involving a private placement of equity. Key changes include:
- Equity Dilution: Issuance of 16 million new shares to institutional investors.
- Extension of Rights: The Right of Participation held by the Purchasers under the June 30, 2022 Securities Purchase Agreement has been extended to December 31, 2025.
- Debt Repayment Covenant: The Company agreed that if it sells shares via an at-the-market offering or equity line of credit, 25% of the net proceeds must be used to repay the principal on outstanding Debentures.
Guidance, Outlook, and Risks
Management Commentary: The filing contains standard forward-looking statements regarding future events, performance, and assumptions. Management does not intend to update these statements to conform to actual results except as required by law.
Risks and Contingencies: Actual results may differ significantly from anticipated results due to risks and uncertainties relating to the industry, operations, and potential acquisitions. The filing does not detail specific new risks beyond the standard disclaimer.
Unusual Items: The filing does not disclose unusual items outside of the standard capital raise mechanics.
Investor Verification Checklist
- Verify the exact number of outstanding shares post-issuance to assess dilution impact.
- Review the June 30, 2022 Securities Purchase Agreement to understand the terms of the "Debentures" and the specific "Right of Participation."
- Confirm the current status of any outstanding Debentures and the Company's ability to meet the new 25% net proceeds repayment covenant.
- Check the prospectus supplement on Form 424(b)(4) filed on October 15, 2024, for full registration details.